rs145851520
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_005236.3(ERCC4):c.1031A>G(p.Tyr344Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000391 in 1,612,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y344F) has been classified as Likely benign.
Frequency
Consequence
NM_005236.3 missense
Scores
Clinical Significance
Conservation
Publications
- xeroderma pigmentosum group FInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
- Fanconi anemia complementation group QInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- XFE progeroid syndromeInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC4 | NM_005236.3 | c.1031A>G | p.Tyr344Cys | missense_variant | Exon 6 of 11 | ENST00000311895.8 | NP_005227.1 | |
| ERCC4 | XM_011522424.4 | c.1169A>G | p.Tyr390Cys | missense_variant | Exon 7 of 12 | XP_011520726.1 | ||
| ERCC4 | XM_047433774.1 | c.242A>G | p.Tyr81Cys | missense_variant | Exon 3 of 8 | XP_047289730.1 | ||
| ERCC4 | XM_011522427.2 | c.-439A>G | upstream_gene_variant | XP_011520729.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000399 AC: 10AN: 250694 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460342Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726648 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74374 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 344 of the ERCC4 protein (p.Tyr344Cys). This variant is present in population databases (rs145851520, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ERCC4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1058221). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ERCC4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at